Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Alpha Szenszor partners with Technion Israel to develop exhaled-breath lung cancer diagnostic

14 Mar 2013

Executive Summary

Alpha Szenszor Inc. (carbon nanotube sensor technology for life science applications) has chosen the Technion Israel Institute of Technology as its first partner in the development of a breath-based diagnostic for lung cancer.
Deal Industry
  • In Vitro Diagnostics
  • In Vitro Diagnostics
    • Biosensors
  • Biotechnology
    • Nanotechnology, Chips, etc.
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By